Market Cap 711.53M
Revenue (ttm) 70.01M
Net Income (ttm) 9.95M
EPS (ttm) N/A
PE Ratio 44.78
Forward PE 29.81
Profit Margin 14.21%
Debt to Equity Ratio 0.00
Volume 409,700
Avg Vol 292,754
Day's Range N/A - N/A
Shares Out 20.11M
Stochastic %K 93%
Beta 1.13
Analysts Strong Sell
Price Target $48.20

Latest News on SLP

Simulations Plus: Benefiting From FDA Modernization And AI

Apr 16, 2025, 8:30 AM EDT - 7 days ago

Simulations Plus: Benefiting From FDA Modernization And AI


Simulations Plus, Inc. (SLP) Q2 2025 Earnings Call Transcript

Apr 3, 2025, 8:44 PM EDT - 20 days ago

Simulations Plus, Inc. (SLP) Q2 2025 Earnings Call Transcript


Top 3 Health Care Stocks That Are Set To Fly This Month

Mar 26, 2025, 7:06 AM EDT - 4 weeks ago

Top 3 Health Care Stocks That Are Set To Fly This Month

ARVN IOVA


Simulations Plus, Inc. (SLP) Q1 2025 Earnings Call Transcript

Jan 7, 2025, 9:08 PM EST - 3 months ago

Simulations Plus, Inc. (SLP) Q1 2025 Earnings Call Transcript


Simulations Plus, Inc. (SLP) Q4 2024 Earnings Call Transcript

Oct 23, 2024, 11:55 PM EDT - 6 months ago

Simulations Plus, Inc. (SLP) Q4 2024 Earnings Call Transcript


Simulations Plus Releases DILIsym® X

Aug 1, 2024, 8:30 AM EDT - 9 months ago

Simulations Plus Releases DILIsym® X


Simulations Plus Releases ADMET Predictor® Version 12

Jul 30, 2024, 8:30 AM EDT - 9 months ago

Simulations Plus Releases ADMET Predictor® Version 12


Simulations Plus, Inc. (SLP) Q3 2024 Earnings Call Transcript

Jul 2, 2024, 7:28 PM EDT - 10 months ago

Simulations Plus, Inc. (SLP) Q3 2024 Earnings Call Transcript


QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus

Jun 12, 2024, 8:58 AM EDT - 11 months ago

QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus


U.S. FDA Renews DILIsym® Software Licenses for 7th Year

Apr 4, 2024, 8:30 AM EDT - 1 year ago

U.S. FDA Renews DILIsym® Software Licenses for 7th Year

ESG


Simulations Plus, Inc. (SLP) Q2 2024 Earnings Call Transcript

Apr 3, 2024, 11:15 PM EDT - 1 year ago

Simulations Plus, Inc. (SLP) Q2 2024 Earnings Call Transcript


Simulations Plus Launches Corporate Development Initiative

Feb 13, 2024, 9:15 AM EST - 1 year ago

Simulations Plus Launches Corporate Development Initiative


Simulations Plus Releases GastroPlus® Version 9.9

Jan 30, 2024, 8:30 AM EST - 1 year ago

Simulations Plus Releases GastroPlus® Version 9.9